Home › Funds › TSP Capital Management Group, LLC › CLDX

TSP Capital Management Group, LLC position in CLDX

CELLDEX THERAPEUTICS INC NEW · Health Care

TSP Capital Management Group, LLC reported holding 371,127 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 3.03% of its reported portfolio and ranking #14 among its reported holdings. TSP Capital Management Group, LLC has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)371.13K sh
Reported value held$12.03M
Portfolio Weight3.03%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How TSP Capital Management Group, LLC's CLDX position evolved

TSP Capital Management Group, LLC first disclosed a stake in CLDX in Q3 2023 at 251,695 shares (US$6.9M). The position peaked in Q2 2026 at 371,127 shares, worth US$13.8M. Across 13 filings, TSP Capital Management Group, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 371,127 shares valued at US$12.0M. Notable position changes include a 50% increase in Q1 2025 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 251.69K $6.93M New
Q4 2023 251.50K $9.97M Hold
Q1 2024 249.22K $10.46M Reduce
Q2 2024 249.22K $9.22M Hold
Q3 2024 247.82K $8.42M Reduce
Q4 2024 223.34K $5.64M Reduce
Q1 2025 335.98K $6.10M Add
Q2 2025 371.43K $7.56M Add
Q3 2025 375.93K $9.73M Add
Q4 2025 375.13K $10.19M Hold
Q1 2026 375.13K $11.90M Hold
Q2 2026 371.13K $13.81M Reduce
Q3 2026 371.13K $12.03M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDX and 13F data

CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 44 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDX

All CLDX fund holders →

FAQ

How long has TSP Capital Management Group, LLC held CLDX?

TSP Capital Management Group, LLC has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TSP Capital Management Group, LLC's current position in CLDX?

As of Q3 2026, TSP Capital Management Group, LLC holds 371.13K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $12.03M, representing 3.03% of its reported portfolio and ranking #14.

Has TSP Capital Management Group, LLC been buying or selling CLDX?

In the latest 13F filing (Q3 2026), TSP Capital Management Group, LLC held unchanged its position in CLDX. The position peaked in Q2 2026 at 371.13K shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.